标题
New Treatment Addressing the Pathogenesis of Psoriasis
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 20, Pages 7488
出版商
MDPI AG
发表日期
2020-10-14
DOI
10.3390/ijms21207488
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis
- (2020) Karen M. Page et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
- (2019) Hervé Bachelez et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations
- (2019) Chihiro Imura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Psoriasis Pathogenesis and Treatment
- (2019) Adriana Rendon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Meta‐analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
- (2019) Han Witjes et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate‐to‐severe psoriasis: a pooled analysis of two randomized controlled trials
- (2019) A. Blauvelt et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
- (2019) Masutaka Furue et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dendritic cells: The driver of psoriasis
- (2019) Ao Wang et al. JOURNAL OF DERMATOLOGY
- Aryl Hydrocarbon Receptor in Cutaneous Vascular Endothelial Cells Restricts Psoriasis Development by Negatively Regulating Neutrophil Recruitment
- (2019) Zhenlai Zhu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- (2019) Farzan Solimani et al. Frontiers in Immunology
- Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment
- (2018) Ming Ji et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3)
- (2018) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17
- (2018) L.H. Eaton et al. BRITISH JOURNAL OF DERMATOLOGY
- A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test
- (2018) E.G. Kang et al. BRITISH JOURNAL OF DERMATOLOGY
- Scanning the Immunopathogenesis of Psoriasis
- (2018) Andrea Chiricozzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modeling clinical efficacy of the S1P receptor modulator ponesimod in psoriasis
- (2018) Andreas Krause et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- RNase 7 Strongly Promotes TLR9-Mediated DNA Sensing by Human Plasmacytoid Dendritic Cells
- (2018) Verena Kopfnagel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
- (2018) Vrajesh Bhaskarbhai Pandya et al. JOURNAL OF MEDICINAL CHEMISTRY
- Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis
- (2018) Lipeng Tang et al. Frontiers in Immunology
- Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1
- (2018) Mark Bell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Pooled Analysis of Week 16 Data from 3 Randomized Controlled Trials
- (2018) A. Blauvelt et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long‐term safety and drug survival of acitretin in psoriasis: a retrospective observational study
- (2018) Leena Chularojanamontri et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- A Phase 2, Randomized Dose-Finding Study of Tapinarof (GSK2894512 Cream) for the Treatment of Plaque Psoriasis
- (2018) Kevin Robbins et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- More tolerance for dendritic cells in psoriasis
- (2017) Timo Buhl et al. EXPERIMENTAL DERMATOLOGY
- Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes
- (2017) Judilyn Fuentes-Duculan et al. EXPERIMENTAL DERMATOLOGY
- Psoriasis pathogenesis and the development of novel targeted immune therapies
- (2017) Jason E. Hawkes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study
- (2017) JianZhong Zhang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Pathogenesis of psoriasis and development of treatment
- (2017) Eisaku Ogawa et al. JOURNAL OF DERMATOLOGY
- Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10
- (2017) Alexandra Zanin-Zhorov et al. JOURNAL OF IMMUNOLOGY
- Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis
- (2017) Elisa Martini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans
- (2017) Susan H. Smith et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
- (2017) Rajkumar Ganesan et al. mAbs
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Dendritic cell subsets
- (2017) Christophe Macri et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
- (2016) R. Flynn et al. BLOOD
- Binding Affinity and Interaction of LL-37 with HLA-C*06:02 in Psoriasis
- (2016) Tomotaka Mabuchi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The role of epidermal sphingolipids in dermatologic diseases
- (2016) Sonia Borodzicz et al. Lipids in Health and Disease
- To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling
- (2016) Wee Siong Chew et al. PHARMACOLOGICAL RESEARCH
- Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation
- (2016) Tej Pratap Singh et al. Nature Communications
- Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases
- (2016) Daniele D’Ambrosio et al. Therapeutic Advances in Chronic Disease
- Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials
- (2016) Jonathan West et al. PLoS One
- Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation
- (2016) Hideaki Takagi et al. Scientific Reports
- Treating psoriasis with adalimumab
- (2016) Kenneth Gordon Therapeutics and Clinical Risk Management
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
- (2015) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
- (2015) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Secukinumab (AIN457) for the treatment of psoriasis
- (2015) Anna López-Ferrer et al. Expert Review of Clinical Immunology
- “Inflammatory skin march”: IL-1–mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events
- (2015) Keiichi Yamanaka et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Regulatory dendritic cells in autoimmunity: A comprehensive review
- (2015) Juan Liu et al. JOURNAL OF AUTOIMMUNITY
- An autoimmune “attack” on melanocytes triggers psoriasis and cellular hyperplasia
- (2015) James G. Krueger JOURNAL OF EXPERIMENTAL MEDICINE
- Melanocyte antigen triggers autoimmunity in human psoriasis
- (2015) Akiko Arakawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis
- (2015) Dorothea Terhorst et al. JOURNAL OF IMMUNOLOGY
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
- (2015) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- The Aryl Hydrocarbon Receptor: Multitasking in the Immune System
- (2014) Brigitta Stockinger et al. Annual Review of Immunology
- Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA
- (2014) Roberto Lande et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: A role for interferon-alpha in dendritic cell activation by imiquimod
- (2014) Azumi Ueyama et al. JOURNAL OF DERMATOLOGY
- Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial
- (2014) Andrea Vaclavkova et al. LANCET
- Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
- (2014) Alexandra Zanin-Zhorov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human dendritic cell subsets
- (2013) Matthew Collin et al. IMMUNOLOGY
- Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis
- (2013) Katrin Schaper et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Th17 Cells Carrying TCR Recognizing Epidermal Autoantigen Induce Psoriasis-like Skin Inflammation
- (2013) S. Nishimoto et al. JOURNAL OF IMMUNOLOGY
- Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
- (2013) Gregory T. Kunkel et al. NATURE REVIEWS DRUG DISCOVERY
- Selective ROCK2 inhibition in focal cerebral ischemia
- (2013) Jeong Hyun Lee et al. Annals of Clinical and Translational Neurology
- Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
- (2012) Jason G. Cyster et al. Annual Review of Immunology
- Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Antimicrobial peptides in the pathogenesis of psoriasis
- (2012) Shin MORIZANE et al. JOURNAL OF DERMATOLOGY
- α-MSH-Stimulated Tolerogenic Dendritic Cells Induce Functional Regulatory T Cells and Ameliorate Ongoing Skin Inflammation
- (2012) Matteo Auriemma et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IFN-α Enhances IL-22 Receptor Expression in Keratinocytes: A Possible Role in the Development of Psoriasis
- (2012) Mikiko Tohyama et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study
- (2012) S. Dogra et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity
- (2011) Wolf-Henning Boehncke et al. EXPERIMENTAL DERMATOLOGY
- Dendritic cell control of tolerogenic responses
- (2011) Santhakumar Manicassamy et al. IMMUNOLOGICAL REVIEWS
- IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway
- (2011) Kyung-Ah Cho et al. INTERNATIONAL IMMUNOLOGY
- Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses
- (2011) Anja Hänsel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands
- (2011) Shin Morizane et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Selective Sphingosine 1-Phosphate Receptor 1 Agonist Ponesimod Protects against Lymphocyte-Mediated Tissue Inflammation
- (2011) L. Piali et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis
- (2011) A Maza et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses
- (2010) Roberto Lande et al. Annals of the New York Academy of Sciences
- Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells
- (2010) Jean-Marie Ramirez et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Angiogenesis drives psoriasis pathogenesis
- (2010) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice
- (2010) Partha S. Biswas et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- 2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists
- (2010) Martin H. Bolli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
- (2010) Pieter C. M. Res et al. PLoS One
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling
- (2009) Stefanie Eyerich et al. JOURNAL OF CLINICAL INVESTIGATION
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
- (2009) Yuping Lai et al. TRENDS IN IMMUNOLOGY
- Sphingosine 1-Phosphate Restrains Insulin-Mediated Keratinocyte Proliferation via Inhibition of Akt through the S1P2 Receptor Subtype
- (2008) Melanie Schüppel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started